Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

81.26
BATS BZX Real-Time Price
As of 10:29am ET
 +0.40 / +0.49%
Today’s Change
69.35
Today|||52-Week Range
89.27
+14.08%
Year-to-Date
MDT Regular Dividend: MDT began trading ex-dividend on 03/22/17. A $0.43 dividend will be paid to shareholders of record as of 03/24/17.
Primecap Sells NVIDIA, Microsoft, Union Pacific
Mar 23 / GuruFocus News - Paid Partner Content
Medtronic's Positive 2-Year SURTAVI Data Boosts Corevalve
Mar 20 / Zacks.com - Paid Partner Content
Medtronic's (MDT) CoreValve Evolut Pro Receives FDA Approval
Mar 23 / Zacks.com - Paid Partner Content
Mazor Robotics-Medtronic's Mazor X Partnership Strengthens
Mar 20 / Zacks.com - Paid Partner Content
Intel Elects Two New Members to its Board
Mar 23 / TheStreet.com - Paid Partner Content
Dividend Aristocrats: Medtronic vs. Becton, Dickinson & Company
Mar 19 / GuruFocus News - Paid Partner Content
MedTech Long-Term Prospects Impress: Which Stocks to Buy?
Mar 22 / Zacks.com - Paid Partner Content
Medtronic's Melody TPV Wins FDA for Less-Invasive Treatment
Mar 16 / Zacks.com - Paid Partner Content
Dodge & Cox Buys Bristol-Myers Squibb Company, Zayo Group Holdings, Medtronic PLC, Se...
Mar 20 / GuruFocus News - Paid Partner Content
Medtronic's New Reveal LINQ ICM Gets FDA 510(k) Clearance
Mar 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close80.86
Today’s open80.93
Day’s range80.85 - 81.39
Volume11,290
Average volume (3 months)6,192,758
Market cap$110.7B
Dividend yield2.12%
Data as of 10:29am ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+2.90%
Earnings growth (this year)+4.75%
Earnings growth (next 5 years)+6.73%
Revenue growth (last year)+42.31%
P/E ratio28.8
Price/Sales3.91
Price/Book2.17

Competitors

 Today’s
change
Today’s
% change
RMDResMed Inc+0.39+0.55%
VARVarian Medical Syste...-0.03-0.03%
NVRONevro Corp+0.74+0.81%
LIVNLivaNova PLC+0.46+0.93%
Data as of 10:32am ET, 03/24/2017

Financials

Next reporting dateMay 25, 2017
EPS forecast (this quarter)$1.31
Annual revenue (last year)$28.8B
Annual profit (last year)$3.5B
Net profit margin12.27%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Omar S. Ishrak
Chief Financial Officer &
Executive Vice President
Karen L. Parkhill
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs